Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes Comparison of TAMIS-TME Versus Transanal Minimally Invasive Locoregional Resection for T2 Low Rectal Cancer: an Open Label Study

NCT02488577 is registered in ClinicalTrials.gov with Osama Mohammad Ali ElDamshety as lead sponsor.

NCT NCT02488577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02488577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes Comparison of TAMIS-TME Versus Transanal Minimally Invasive Locoregional Resection for T2 Low Rectal Cancer: an Open Label Study
Lead sponsor
Osama Mohammad Ali ElDamshety
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2015
Completion date
October 31, 2019
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

low rectal cancer